Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 2/2016

01-02-2016 | Original Article

Patient and family experiences with accessing telephone cancer treatment symptom support: a descriptive study

Authors: Dawn Stacey, Esther Green, Barbara Ballantyne, Myriam Skrutkowski, Angela Whynot, Lucie Tardif, Joy Tarasuk, Meg Carley, For the Pan-Canadian Oncology Symptom Triage and Remote Support (COSTaRS) Team

Published in: Supportive Care in Cancer | Issue 2/2016

Login to get access
Metadata
Title
Patient and family experiences with accessing telephone cancer treatment symptom support: a descriptive study
Authors
Dawn Stacey
Esther Green
Barbara Ballantyne
Myriam Skrutkowski
Angela Whynot
Lucie Tardif
Joy Tarasuk
Meg Carley
For the Pan-Canadian Oncology Symptom Triage and Remote Support (COSTaRS) Team
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2859-6

Other articles of this Issue 2/2016

Supportive Care in Cancer 2/2016 Go to the issue

Erratum

Erratum to: Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study

Original Article

Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study

Original Article

Preventive effects of amino-acid-rich elemental diet Elental® on chemotherapy-induced oral mucositis in patients with colorectal cancer: a prospective pilot study

Review Article

Non-pharmacological cancer pain interventions in populations with social disparities: a systematic review and meta-analysis

Original Article

Xerosis and pruritus as major EGFRI-associated adverse events

Original Article

Assessing the psychosocial needs and program preferences of adolescents and young adults with cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits